Belzutifan Generates Superior PFS, ORR in Pretreated Advanced ccRCC
Treatment with belzutifan produced improvements in progression-free survival and objective response rate vs everolimus in patients with pretreated advanced clear cell renal cell carcinoma.
Source: onclive.com